An Intrinsic Calculation For Addus HomeCare Corporation (NASDAQ:ADUS) Suggests It's 44% Undervalued
Key Insights Addus HomeCare's estimated fair value is US$165 based on 2 Stage Free Cash Flow to Equity Addus HomeCare's US$91.70 share price signals that it might be 44% undervalued The US$105 an
Simply Wall StApr 26 09:07 ET
Express News | Addus Homecare Corp : Barclays Cuts to Underweight From Equal-Weight; Cuts Target Price to $83 From $88
Moomoo 24/7Apr 24 06:43 ET
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
In the preceding three months, 4 analysts have released ratings for Addus HomeCare (NASDAQ:ADUS), presenting a wide array of perspectives from bullish to bearish.The table below provides a snapshot of
BenzingaApr 23 10:00 ET
Addus HomeCare Cut to Underweight From Equal-Weight by Barclays
Addus HomeCare Cut to Underweight From Equal-Weight by Barclays
Dow JonesApr 23 09:59 ET
Express News | Barclays Downgrades Addus HomeCare to Underweight, Announces $83 Price Target
Moomoo 24/7Apr 23 09:49 ET
Addus HomeCare 'Disappointed' With Compensation Requirement in Medicaid Final Rule; Shares Tumble Pre-Bell
Addus HomeCare (ADUS) said Tuesday it was "disappointed" that the Department of Health and Human Services kept a high compensation requirement in its final rule for Medicaid services. Addus shares wer
MT NewswiresApr 23 09:18 ET
Addus HomeCare Comments on Final Department of Health and Human Services Rule
Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, commented on the final rule announced on April 22, 2024, by the Department of Health and Human Services (HHS) known as "Ensuring Access to
BusinesswireApr 23 08:00 ET
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
TipRanksApr 23 05:40 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)
TipRanksApr 23 05:32 ET
Addus HomeCare Announces First Quarter 2024 Earnings Release and Conference Call
Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2024, on Monday, May 6, 2024, after the market
BusinesswireApr 22 11:00 ET
Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024
Yahoo FinanceApr 13 12:18 ET
Addus HomeCare Insiders Sell US$3.4m Of Stock, Possibly Signalling Caution
The fact that multiple Addus HomeCare Corporation (NASDAQ:ADUS) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzin
Simply Wall StApr 11 06:45 ET
Investors in Addus HomeCare (NASDAQ:ADUS) Have Seen Decent Returns of 53% Over the Past Five Years
Yahoo FinanceApr 9 10:31 ET
Jim Cramer Recommends Five Small-cap Health-care Stocks
CNBC's Jim Cramer said he thinks it could be a good year for small-cap health stocks and shared his top health-care picks. "I think 2024 could ultimately be the year that small-cap stocks get their mojo back," he said. "This is a group that went out of style when interest rates soared and they'll work a lot better as rates come down."
CNBCApr 5 18:45 ET
ADUS Vs. USPH: Which Stock Should Value Investors Buy Now?
Yahoo FinanceApr 3 11:40 ET
Addus HomeCare(ADUS.US) Officer Sells US$11,328.37 in Common Stock
$Addus HomeCare(ADUS.US)$ Officer Stevenson Roberton James sold 109 shares of Common Stock on Apr 1, 2024 at an average price of $103.93 for a total value of $11,328.37.Source: Announcement What is st
moomoo NewsApr 2 16:50 ET
4 Analysts Assess Addus HomeCare: What You Need To Know
During the last three months, 4 analysts shared their evaluations of Addus HomeCare (NASDAQ:ADUS), revealing diverse outlooks from bullish to bearish.Summarizing their recent assessments, the table be
BenzingaMar 26 14:01 ET
Addus HomeCare Price Target Maintained With a $118.00/Share by Oppenheimer
Addus HomeCare Price Target Maintained With a $118.00/Share by Oppenheimer
Dow JonesMar 26 10:15 ET
Addus HomeCare Is Maintained at Outperform by Oppenheimer
Addus HomeCare Is Maintained at Outperform by Oppenheimer
Dow JonesMar 26 10:15 ET
Express News | Oppenheimer Maintains Outperform on Addus HomeCare, Maintains $118 Price Target
Moomoo 24/7Mar 26 10:05 ET
No Data
No Data